ELECTRICAL RESISTIVITY OF ALPHA -CYCLODEXTRIN-KI-I₂4H₂O CRYSTALSOZA A.1982; PHYSICA STATUS SOLIDI. (B). BASIC RESEARCH; ISSN 0370-1972; DDR; DA. 1982; VOL. 114; NO 2; PP. K171-K176; BIBL. 20 REF.Article

Electrical conductivity of phenoxazine-iodine (2:3) and phenothiazine-iodine (2:3)OZA, A. T.Molecular crystals and liquid crystals (1969). 1984, Vol 104, Num 3-4, pp 377-387, issn 0026-8941Article

Nickel complexes of 1,10-phenanthroline and 2,2'-bipyridyl with strong intermolecular interactionsOZA, A. T.Crystal research and technology (1979). 1988, Vol 23, Num 3, pp 385-391, issn 0232-1300Article

Infrared absorption study of organic polyiodide chain complexesOZA, A. T.Journal of polymer science. Polymer physics edition. 1986, Vol 24, Num 10, pp 2267-2273, issn 0098-1273Article

Optical absorption study of polyodide chain complexesOZA, A. T.Thin solid films. 1986, Vol 142, Num 2, pp 153-167, issn 0040-6090Article

Oxidation and electrical conductivity of metal chain dioximesOZA, A. T.Czechoslovak journal of physics. 1993, Vol 43, Num 8, pp 821-828, issn 0011-4626Article

Electrical conduction in some inclusion compounds of iodineOZA, A. T.Physica status solidi. A. Applied research. 1983, Vol 80, Num 2, pp 573-579, issn 0031-8965Article

Optical and infrared absorption study of TMPD-iodine complexOZA, A. T.Solid state communications. 1989, Vol 71, Num 11, pp 1005-1009, issn 0038-1098Article

Detection of a weak surface magnetic field on Sirius A: are all tepid stars magnetic?PETIT, P; LIGNIERES, F; THEADO, S et al.Astronomy and astrophysics (Berlin. Print). 2011, Vol 532, issn 0004-6361, L13.1-L13.4, 2Article

Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland : a survey of Irish microbiology laboratoriesFITZPATRICK, F; OZA, A; GILLEECE, A et al.The Journal of hospital infection. 2008, Vol 68, Num 4, pp 315-321, issn 0195-6701, 7 p.Article

Integration of new or experimental treatment options and new approaches to clinical trialsQUINN, M; PFISTERER, J; PECORELLI, S et al.Annals of oncology. 2005, Vol 16, pp viii30-viii35, issn 0923-7534, SUP8Conference Paper

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancerGORE, M; OZA, A; RUSTIN, G et al.European journal of cancer (1990). 2002, Vol 38, Num 1, pp 57-63, issn 0959-8049Article

Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP//EVA, in the initial treatment of Hodgkin's diseaseRADFORD, J. A; CROWTHER, D; JOHNSON, R. J et al.Journal of clinical oncology. 1995, Vol 13, Num 9, pp 2379-2385, issn 0732-183XArticle

Management of stage II Hodgkin's disease : 15 years experience at St. Bartholomew's hospitalGANESAN, T. S; OZA, A; PERRY, N et al.Annals of oncology. 1992, Vol 3, Num 5, pp 349-356, issn 0923-7534Article

Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011NIELSEN, J; MAZICK, A; NUNES, B et al.Epidemiology and infection. 2013, Vol 141, Num 9, pp 1996-2010, issn 0950-2688, 15 p.Article

What price supersonic speed? an applied market research case study Part 2CHUDOBA, B; OZA, A; COLEMAN, G et al.Aeronautical Journal. 2008, Vol 112, Num 1130, pp 219-231, issn 0001-9240, 13 p.Article

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomasDURAN, I; KORTMANSKY, J; BIRLE, D et al.British journal of cancer. 2006, Vol 95, Num 9, pp 1148-1154, issn 0007-0920, 7 p.Article

Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers : a Princess Margaret Hospital Phase II Consortium studyHOTTE, S. J; OZA, A; WINQUIST, E. W et al.Annals of oncology. 2006, Vol 17, Num 2, pp 334-340, issn 0923-7534, 7 p.Article

Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumorsMOORE, M; HIRTE, H. W; SIU, L et al.Annals of oncology. 2005, Vol 16, Num 10, pp 1688-1694, issn 0923-7534, 7 p.Article

Liarozole fumarate (R85246) : a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancerGOSS, P. E; OZA, A; GOEL, R et al.Breast cancer research and treatment. 2000, Vol 59, Num 1, pp 55-68, issn 0167-6806Article

Phase II trial of vorinostat in advanced melanomaHAAS, N. B; QUIRT, I; VONMEHREN, M et al.Investigational new drugs. 2014, Vol 32, Num 3, pp 526-534, issn 0167-6997, 9 p.Article

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyKÖBEL, M; MADORE, J; LELE, S et al.British journal of cancer. 2014, Vol 111, Num 12, pp 2297-2307, issn 0007-0920, 11 p.Article

A phase I study of ^99mTc-hR3 (DiaCIM®), a humanized immunoconjugate directed towards the epidermal growth factor receptorVALLIS, K. A; REILLY, R. M; CHEN, P et al.Nuclear medicine communications. 2002, Vol 23, Num 12, pp 1155-1164, issn 0143-3636, 10 p.Article

Phase ii feasibility study of sequential couplets of cisplatin/topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer : A National Cancer Institute of Canada Clinical Trials Group studyHOSKINS, P; EISENHAUER, E; VERGOTE, I et al.Journal of clinical oncology. 2000, Vol 18, Num 24, pp 4038-4044, issn 0732-183XArticle

Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy : Results of a prospective treatment protocolWONG, R; MILOSEVIC, M; MURPHY, J et al.International journal of radiation oncology, biology, physics. 1999, Vol 45, Num 3, pp 657-665, issn 0360-3016Article